Skip to main content

Sanofi, Regeneron start testing arthritis drug to fight coronavirus

A Sanofi sign outside the French drugmaker's Paris headquarters.
A Sanofi sign outside the French drugmaker's Paris headquarters. © Christian Hartmann, REUTERS

Sanofi SA and partner Regeneron Pharmaceuticals Inc have started a clinical trial of their rheumatoid arthritis drug Kevzara as a treatment for the coronavirus, the companies said on Monday.

Advertising

Enrolments for the mid-to-late stage trial will begin immediately, and the companies anticipate the trial will test up to 400 patients.

Kevzara is an infection-fighting protein known as monoclonal antibody.

Regeneron in February announced a partnership with the US Department of Health and Human Services to develop a coronavirus treatment, and had said it would focus on monoclonal antibodies.

(REUTERS)

Daily news briefReceive essential international news every morning

Page not found

The content you requested does not exist or is not available anymore.